anmelden
SLI
2.143,87
PKT
+4,47
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.12.18 | UBS buy | Goldman Sachs Group Inc. | |
| 20.12.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 19.12.18 | Nestlé buy | Baader Bank | |
| 19.12.18 | UBS buy | Goldman Sachs Group Inc. | |
| 18.12.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 18.12.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 18.12.18 | UBS buy | Deutsche Bank AG | |
| 17.12.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 17.12.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 17.12.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 17.12.18 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 14.12.18 | Novartis Equal-Weight | Morgan Stanley | |
| 14.12.18 | UBS Equal-Weight | Morgan Stanley | |
| 14.12.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.12.18 | Roche overweight | Morgan Stanley | |
| 14.12.18 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.12.18 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 14.12.18 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.12.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 13.12.18 | UBS buy | Kepler Cheuvreux | |
| 13.12.18 | Holcim overweight | Morgan Stanley | |
| 13.12.18 | UBS Sector Perform | RBC Capital Markets | |
| 13.12.18 | Swiss Re overweight | Barclays Capital | |
| 13.12.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 13.12.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 12.12.18 | UBS Sector Perform | RBC Capital Markets | |
| 12.12.18 | UBS Equal-Weight | Morgan Stanley | |
| 12.12.18 | UBS buy | Deutsche Bank AG | |
| 12.12.18 | UBS overweight | JP Morgan Chase & Co. | |
| 12.12.18 | UBS buy | Goldman Sachs Group Inc. | |
| 12.12.18 | UBS Equal weight | Barclays Capital | |
| 12.12.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 12.12.18 | UBS overweight | JP Morgan Chase & Co. | |
| 12.12.18 | UBS overweight | JP Morgan Chase & Co. | |
| 11.12.18 | Givaudan Equal-Weight | Morgan Stanley | |
| 11.12.18 | UBS buy | Goldman Sachs Group Inc. | |
| 11.12.18 | Swiss Re Sector Perform | RBC Capital Markets | |
| 11.12.18 | Novartis buy | Jefferies & Company Inc. | |
| 11.12.18 | Roche buy | Jefferies & Company Inc. |